Organon Pharma (UK) Limited (manufacturer of unpackaged product, primary and secondary packaging, quality control)
UkraineAll drugs from this manufacturer
-
The drug is used as add-on treatment for bronchial asthma (in children aged 2 to 5 years), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Dosage form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate) that is not adequately controlled by other medications. It is also used for the prevention of exercise-induced asthma and to relieve the symptoms of seasonal or perennial allergic rhinitis.
Dosage form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03